Unknown

Dataset Information

0

Does degree of androgen suppression matter in hormone-sensitive prostate cancer?

ABSTRACT:

SUBMITTER: Suzman DL 

PROVIDER: S-EPMC4886659 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Does degree of androgen suppression matter in hormone-sensitive prostate cancer?

Suzman Daniel L DL   Antonarakis Emmanuel S ES  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20150302 10

Similar Datasets

Unknown Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway.
| S-EPMC12707075 | biostudies-literature
Unknown Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison.
| S-EPMC12908864 | biostudies-literature
Unknown Androgen receptor modulatory miR-1271-5p can promote hormone sensitive prostate cancer cell growth.
| S-EPMC11390458 | biostudies-literature
Unknown Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer.
| S-EPMC10771454 | biostudies-literature
Unknown FRI475 The Impact Of Suppression Of Androgen Signaling On Thyroid Hormone Homeostasis In Prostate Cancer Patients
| S-EPMC10555396 | biostudies-literature
Unknown Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.
| S-EPMC3219545 | biostudies-literature
Unknown HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.
| S-EPMC11384952 | biostudies-literature
Unknown Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review.
| S-EPMC11842892 | biostudies-literature
Unknown Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
| S-EPMC12325587 | biostudies-literature
Unknown Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
| S-EPMC5805480 | biostudies-literature